Comparing two catheter treatments for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study compares two different catheters that use pulsed field ablation to treat a type of irregular heartbeat called persistent atrial fibrillation. The goal is to see which one works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with persistent atrial fibrillation that has lasted for at least 7 days but less than 365 days.
- You have symptoms from your atrial fibrillation, like palpitations, shortness of breath, or fatigue.
- You have had no prior surgery or catheter procedure to treat atrial fibrillation.
- You are willing to attend all follow-up visits and tests.
- You do not have any conditions that would make the procedure unsafe, such as severe heart failure or blood clots in the heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
This study compares three approaches to treat persistent atrial fibrillation (AF) that lasts more than 7 days. It tests whether isolating the pulmonary veins alone is enough, or if also targeting low-voltage areas (scarred heart tissue) during either normal rhythm or AF works better.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial tests two different catheters that use pulsed field energy to treat atrial fibrillation (a heart rhythm problem). It aims to find which one works better for people who need blood thinners but have a high risk of bleeding.
This trial compares two types of special catheters (thin tubes) used during a procedure called ablation to treat atrial fibrillation (irregular heartbeat). It aims to see which catheter works better during the procedure, and may help improve future treatments for people with heart rhythm problems.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.